| Ausstehende Aktien | 10,306,079 shares |
| Insider-Aktien | 5.126.831 shares |
| Insider-Besitz | 49,75 % |
| Insider gesamt | 32 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
9016 out of 10791
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Soligenix, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Robert N Brey | 10.000 | ||
| Keith L Brownlie Director - [D] | 50.000 | 3.659 | |
| Marco Maria Brughera Director - [D] | 2.750 | 177 | |
| Cyrille F Buhrman Director - [D] | 4.900.020 | 4.900.020 | |
| Paolo Cavazza - | 293.510 | 18.936 | |
| Enrico Cavazza - | 293.510 | 18.936 | |
| Francesca Cavazza - | 293.510 | 18.936 | |
| Preta Martina Cavazza - | 293.510 | 18.936 | |
| Silvia Cavazza - | 293.510 | 18.936 | |
| Cote Timothy R. Director - [D] | 50.634 | 3.165 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Oreola Donini | 70.000 | ||
|
Corp Plc Elan
10% Owner -
|
162.600 | 162.600 | |
|
Elan International Services Ltd
10% Owner -
|
162.600 | 162.600 | |
|
Elan Pharmaceutical Investments Ii Ltd
10% Owner -
|
1.468.900 | 1.468.900 | |
|
Elan Pharmaceutical Investments Ltd
10% Owner -
|
162.600 | 162.600 | |
| SPA Essetifin - | 293.510 | 18.936 | |
| Guarino Jonathan L. Senior Vice President and CFO - [O] | 11.000 | 710 | |
| Kevin Horgan | 85.000 | ||
|
Corp Intrexon
10% Owner -
|
85.397 | 5.509 | |
|
Randal J Kirk
10% Owner -
|
85.397 | 5.509 | |
| Karen R Krumeich SVP and CFO - [O] | 26.000 | 1.902 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Anthony Gregg Lapointe Director - [D] | 73.781 | 5.399 | |
|
Leadiant Biosciences, Inc.
10% Owner -
|
293.510 | 18.936 | |
| Parks Diane L. Director - [D] | 14.940 | 964 | |
|
Pearson Mark E.
Director, 10% Owner -
[D]
|
78.338 | 5.054 | |
| Rubin Robert J. Director - [D] | 4.385 | 283 | |
| Christopher J Schaber CHAIRMAN, CEO AND PRESIDENT, Director - [D] [O] | 15.511 | 15.511 | |
|
Sigma Tau International Sa
10% Owner -
|
2.711.393 | 3.967.889 | |
|
Sigma-Tau America S.A.
10% Owner -
|
2.711.393 | 3.967.889 | |
| Richard Straube SENIOR VICE PRESIDENT AND CMO - [O] | 8.000 | 516 | |
| Joseph Michael Warusz VP of Finance/Acting CFO - [O] | 12.955 | 948 | |
| Jerome B Zeldis Director - [D] | 22.917 | 1.479 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in SNGX / Soligenix, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in SNGX / Soligenix, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | 2025-10-02 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,3217 | 15.132 | 20 | 15.511 | ||||
| 2023-05-05 | 3 | Cote Timothy R. Silk Road Therapeutics, Inc. | SNGX | Common Stock | I | 25.317 | ||||||||
| 2022-05-18 | 2022-05-18 | 4 | Straube Richard | SNGX | COMMON STOCK | D | 0,5000 | 8.000 | 4 | 8.000 | ||||
| 2022-05-18 | 2022-05-18 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,4433 | 20.000 | 9 | 90.095 | ||||
| 2022-01-21 | 2022-01-21 | 4 | Guarino Jonathan L. | SNGX | Option (Right to Buy) | D | 0,78 | 50.000 | 50.000 | |||||
| 2022-01-21 | 2022-01-21 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,69 | 47.315 | 47.315 | |||||
| 2022-01-04 | 2022-01-03 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,69 | 60.000 | 60.000 | |||||
| 2021-12-20 | 2021-12-17 | 4 | SCHABER CHRISTOPHER J | SNGX | COMMON STOCK | D | 0,7399 | 7.000 | 5 | 70.095 | ||||
| 2021-12-15 | 2021-12-15 | 4 | Guarino Jonathan L. | SNGX | COMMON STOCK | D | 0,7000 | 1.000 | 1 | 11.000 | ||||
| 2021-12-15 | 2021-12-14 | 4 | Guarino Jonathan L. | SNGX | COMMON STOCK | D | 0,7119 | 10.000 | 7 | 10.000 | ||||
| 2021-12-14 | 2021-12-14 | 4 | SCHABER CHRISTOPHER J | SNGX | COMMON STOCK | D | 0,7269 | 10.000 | 7 | 63.095 | ||||
| 2021-12-10 | 2021-12-09 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,78 | 60.000 | 60.000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 0,78 | 50.000 | 50.000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 0,78 | 70.000 | 70.000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 0,78 | 40.000 | 40.000 | |||||
| 2021-09-24 | 2021-09-23 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-09-24 | 2021-09-23 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-09-24 | 2021-09-23 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-09-24 | 2021-09-23 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-05-18 | 2021-05-14 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,9002 | -3.000 | -3 | 22.917 | ||||
| 2021-05-18 | 2021-05-14 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,8880 | 3.000 | 3 | 25.917 | ||||
| 2021-01-04 | 2021-01-04 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,28 | 60.000 | 60.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 2,34 | 70.000 | 70.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 2,34 | 60.000 | 60.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 2,34 | 40.000 | 40.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 2,34 | 40.000 | 40.000 | |||||
| 2020-09-18 | 2020-09-16 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-09-18 | 2020-09-16 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-09-18 | 2020-09-16 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-09-18 | 2020-09-16 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-06-19 | 2020-06-18 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 1,76 | 13.500 | 13.500 | |||||
| 2020-01-02 | 2020-01-02 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,45 | 60.000 | 60.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 1,24 | 60.000 | 60.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 1,24 | 10.000 | 10.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,24 | 60.000 | 60.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 1,24 | 30.000 | 30.000 | |||||
| 2019-11-19 | 2019-11-19 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,9300 | 10.770 | 10 | 53.095 | ||||
| 2019-11-19 | 2019-11-19 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,9250 | 2.000 | 2 | 22.917 | ||||
| 2019-09-23 | 2019-09-23 | 4 | Parks Diane L. | SNGX | Common Stock | D | 0,9284 | 14.940 | 14 | 14.940 | ||||
| 2019-09-23 | 2019-09-19 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,9350 | 4.000 | 4 | 20.917 | ||||
| 2019-09-11 | 2019-09-09 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2019-09-10 | 2019-09-06 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | Pearson Mark E. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-07-10 | 2019-06-28 | 4 | Pearson Mark E. | SNGX | Common Stock | I | 0,7100 | 78.338 | 56 | 78.338 | ||||
| 2019-07-08 | 2019-07-08 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 0,86 | 1.500 | 1.500 | |||||
| 2019-04-22 | 2019-04-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,7154 | 5.000 | 4 | 42.325 | ||||
| 2019-04-22 | 2019-04-22 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,7274 | 10.000 | 7 | 16.917 | ||||
| 2019-01-04 | 2019-01-02 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,96 | 60.000 | 60.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,97 | 60.000 | 60.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2018-10-18 | 2018-10-18 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,1698 | 8.700 | 10 | 37.325 | ||||
| 2018-10-17 | 2018-10-17 | 4 | Pearson Mark E. | SNGX | Common Stock | D | 1,1600 | 170.000 | 197 | 2.500.000 | ||||
| 2018-09-28 | 2018-09-27 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | Pearson Mark E. | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-08-22 | 2018-08-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,4198 | 3.530 | 5 | 28.625 | ||||
| 2018-07-25 | 3 | Pearson Mark E. | SNGX | COMMON STOCK | D | 4.660.000 | ||||||||
| 2018-07-25 | 3 | Pearson Mark E. | SNGX | COMMON STOCK | D | 4.660.000 | ||||||||
| 2018-07-25 | 3 | Pearson Mark E. | SNGX | COMMON STOCK | D | 4.660.000 | ||||||||
| 2018-07-25 | 2018-07-20 | 4 | Pearson Mark E. | SNGX | Stock Option (Right to Buy) | D | 1,22 | 1.500 | 1.500 | |||||
| 2017-12-11 | 2017-12-07 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 2,01 | 35.000 | 35.000 | |||||
| 2017-12-11 | 2017-12-07 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 2,01 | 35.000 | 35.000 | |||||
| 2017-12-11 | 2017-12-07 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 2,01 | 80.000 | 80.000 | |||||
| 2017-12-11 | 2017-12-07 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 2,01 | 35.000 | 35.000 | |||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA | SNGX | Common Stock | D | 2,1200 | 16.416 | 35 | 293.510 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 2,1200 | -16.416 | -35 | 0 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA | SNGX | Common Stock | D | 2,1200 | 5.954 | 13 | 277.094 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 2,1200 | -5.954 | -13 | 0 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA | SNGX | Common Stock | D | 2,1200 | 271.140 | 575 | 271.140 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 2,1200 | -271.140 | -575 | 0 | ||||
| 2017-06-12 | 2017-06-08 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-05-08 | 2017-05-08 | 4 | KIRK RANDAL J by Intrexon | SNGX | Common Stock | I | 2,5400 | -1.881 | -5 | 85.397 | ||||
| 2017-05-08 | 2017-05-08 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 2,5400 | -9.695 | -25 | 440.418 | ||||
| 2017-05-08 | 2017-05-05 | 4 | KIRK RANDAL J by Intrexon | SNGX | Common Stock | I | 2,7000 | -13.893 | -38 | 87.278 | ||||
| 2017-05-08 | 2017-05-05 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 2,7000 | -71.607 | -193 | 450.113 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Warrant to Purchase Common Stock | I | 0,80 | -250.000 | 0 | |||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by Intrexon | SNGX | Common Stock | I | 2,9700 | -2.278 | -7 | 101.171 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 2,9700 | -11.739 | -35 | 521.720 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 4,0100 | -49.875 | -200 | 533.459 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 0,8000 | 250.000 | 200 | 583.334 | ||||
| 2017-04-04 | 2017-03-31 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 2,67 | 20.000 | 20.000 | |||||
| 2017-04-04 | 2017-03-31 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 2,67 | 20.000 | 20.000 | |||||
| 2017-04-04 | 2017-03-31 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 2,67 | 50.000 | 50.000 | |||||
| 2017-04-04 | 2017-03-31 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 2,67 | 20.000 | 20.000 | |||||
| 2016-12-20 | 2016-12-16 | 4 | Brughera Marco Maria | SNGX | Common Stock Warrant | D | 3,95 | 0,0001 | 2.500 | 0 | 2.500 | |||
| 2016-12-20 | 2016-12-16 | 4 | Brughera Marco Maria | SNGX | Common Stock | D | 3,1599 | 2.000 | 6 | 2.750 | ||||
| 2016-12-20 | 2016-12-16 | 4 | RUBIN ROBERT J. | SNGX | Common Stock Warrant | D | 3,95 | 0,0001 | 3.956 | 0 | 3.956 | |||
| 2016-12-20 | 2016-12-16 | 4 | RUBIN ROBERT J. | SNGX | Common Stock | D | 3,1599 | 3.165 | 10 | 4.385 | ||||
| 2016-12-20 | 2016-12-16 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrant | D | 3,95 | 0,0001 | 19.755 | 0 | 19.755 | |||
| 2016-12-20 | 2016-12-16 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 3,1599 | 15.804 | 50 | 25.095 | ||||
| 2016-06-22 | 3 | Krumeich Karen R | SNGX | Common Stock | D | 26.000 | ||||||||
| 2016-06-22 | 3 | Krumeich Karen R | SNGX | Common Stock | D | 26.000 | ||||||||
| 2016-06-22 | 2016-06-16 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 0,74 | 100.000 | 100.000 | |||||
| 2016-06-20 | 2016-06-16 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Donini Oreola | SNGX | Stock Option (Right to Buy) | D | 1,13 | 70.000 | 70.000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Straube Richard | SNGX | Stock Option (Right to Buy) | D | 1,13 | 70.000 | 70.000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Warusz Joseph Michael | SNGX | Option (Right to Buy) | D | 1,13 | 55.000 | 55.000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,13 | 140.000 | 140.000 | |||||
| 2015-12-23 | 2015-12-23 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 1,2700 | 2.500 | 3 | 69.166 | ||||
| 2015-12-23 | 2015-12-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,2878 | 10.000 | 13 | 85.761 | ||||
| 2015-08-31 | 2015-08-31 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Common Stock Warrant | D | 0,30 | -25.000 | 0 | |||||
| 2015-08-31 | 2015-08-31 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Common Stock | D | 0,3000 | 25.000 | 8 | 73.781 | ||||
| 2015-07-01 | 2015-07-01 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrant | D | 0,61 | -7.143 | 0 | |||||
| 2015-07-01 | 2015-07-01 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,6100 | 7.143 | 4 | 82.904 | ||||
| 2015-06-19 | 2015-06-18 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-04-09 | 2015-04-09 | 4 | Brownlie Keith L | SNGX | Common Stock Warrant | D | 0,61 | -14.286 | 0 | |||||
| 2015-04-09 | 2015-04-09 | 4 | Brownlie Keith L | SNGX | Common Stock | D | 0,6100 | 14.286 | 9 | 50.000 | ||||
| 2015-04-09 | 2015-04-09 | 4 | ZELDIS JEROME B | SNGX | Common Stock Warrant | D | 0,61 | -17.857 | 0 | |||||
| 2015-04-09 | 2015-04-09 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,6100 | 17.857 | 11 | 66.666 | ||||
| 2014-12-24 | 2014-12-24 | 4 | Warusz Joseph Michael | SNGX | Common Stock Warrant | D | 1,48 | 4.959 | 4.959 | |||||
| 2014-12-24 | 2014-12-22 | 4 | Warusz Joseph Michael | SNGX | Common Stock | D | 1,2100 | 8.265 | 10 | 12.955 | ||||
| 2014-12-24 | 2014-12-24 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrant | D | 1,48 | 4.959 | 4.959 | |||||
| 2014-12-24 | 2014-12-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,2100 | 8.265 | 10 | 75.761 | ||||
| 2014-12-08 | 2014-12-04 | 4 | Warusz Joseph Michael | SNGX | Option (Right to Buy) | D | 1,50 | 45.000 | 45.000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Straube Richard | SNGX | Stock Option (Right to Buy) | D | 1,50 | 50.000 | 50.000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,50 | 100.000 | 100.000 | |||||
| 2014-08-05 | 2014-08-05 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,01 | -7.500 | 7.500 | |||||
| 2014-08-05 | 2014-08-05 | 4 | Brughera Marco Maria | SNGX | Common Stock | D | 2,0100 | 7.500 | 15 | 7.500 | ||||
| 2014-06-20 | 2014-06-19 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-05-19 | 2014-05-19 | 4 | Warusz Joseph Michael | SNGX | Option (Right to Buy) | D | 0,64 | -4.690 | 25.310 | |||||
| 2014-05-19 | 2014-05-19 | 4 | Warusz Joseph Michael | SNGX | Common Stock | D | 0,6400 | 4.690 | 3 | 4.690 | ||||
| 2014-05-16 | 2014-05-14 | 4 | Brownlie Keith L | SNGX | Option (Right to Buy) | D | 0,30 | -16.667 | 8.333 | |||||
| 2014-05-16 | 2014-05-14 | 4 | Brownlie Keith L | SNGX | Common Stock | D | 0,3000 | 16.667 | 5 | 35.714 | ||||
| 2014-05-14 | 2014-05-13 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,64 | -7.815 | 112.185 | |||||
| 2014-05-14 | 2014-05-13 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,6400 | 7.815 | 5 | 67.496 | ||||
| 2014-01-08 | 2014-01-06 | 4 | Straube Richard | SNGX | Stock Option (Right to Buy) | D | 2,01 | 100.000 | 100.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | BREY ROBERT N | SNGX | Stock Option (Right to Buy) | D | 2,01 | 10.000 | 10.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,01 | 15.000 | 15.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | SCHABER CHRISTOPHER J | SNGX | Stock Option (Right to Buy) | D | 2,01 | 100.000 | 100.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | Warusz Joseph Michael | SNGX | Stock Option (Right to Buy) | D | 2,01 | 45.000 | 45.000 | |||||
| 2013-10-01 | 2013-09-27 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-10-01 | 2013-09-27 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-10-01 | 2013-09-27 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-10-01 | 2013-09-27 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-09-27 | 2013-09-25 | 4 | BREY ROBERT N | SNGX | Stock Option (Right to Buy) | D | 0,68 | 35.000 | 35.000 | |||||
| 2013-09-27 | 2013-09-25 | 4 | HORGAN KEVIN | SNGX | Stock Option (Right to Buy) | D | 0,68 | 85.000 | 85.000 | |||||
| 2013-09-27 | 2013-09-25 | 4 | SCHABER CHRISTOPHER J | SNGX | Stock Option (Right to Buy) | D | 0,68 | 130.000 | 130.000 | |||||
| 2013-09-27 | 2013-09-25 | 4 | Warusz Joseph Michael | SNGX | Stock Option (Right to Buy) | D | 0,68 | 55.000 | 55.000 | |||||
| 2013-06-26 | 3 | INTREXON CORP by Intrexon Corporation | SNGX | Common Stock | I | 1.034.483 | ||||||||
| 2013-06-26 | 3 | INTREXON CORP by NRM VII Holdings | SNGX | Common Stock | I | 3.333.333 | ||||||||
| 2013-06-26 | 2013-06-25 | 4 | Brownlie Keith L | SNGX | Common Stock Warrants | D | 1,65 | 14.286 | 14.285 | |||||
| 2013-06-26 | 2013-06-25 | 4 | Brownlie Keith L | SNGX | Common Stock | D | 1,0500 | 19.047 | 20 | 19.047 | ||||
| 2013-06-26 | 2013-06-25 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrants | D | 1,65 | 7.143 | 7.142 | |||||
| 2013-06-26 | 2013-06-25 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,0500 | 9.523 | 10 | 59.681 | ||||
| 2013-06-26 | 2013-06-25 | 4 | ZELDIS JEROME B | SNGX | Common Stock Warrants | D | 1,65 | 17.857 | 17.857 | |||||
| 2013-06-26 | 2013-06-25 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 1,0500 | 23.809 | 25 | 48.809 | ||||
| 2013-06-24 | 2013-06-20 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,30 | -25.000 | 0 | |||||
| 2013-06-24 | 2013-06-20 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,3000 | 25.000 | 8 | 25.000 | ||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 0,53 | 1 | 1 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 0,53 | 1 | 1 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 0,53 | 1 | 1 | |||||
| 2012-12-21 | 2012-12-20 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-07-25 | 2012-06-21 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-07-25 | 2012-06-21 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-07-25 | 2012-06-21 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-07-25 | 2012-06-21 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-04-11 | 2012-04-10 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,5098 | 9.900 | 5 | 50.157 | ||||
| 2012-01-18 | 2012-01-16 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 333.333 | 805.150 | ||||||
| 2010-06-22 | 2010-06-18 | 4 | RUBIN ROBERT J. | SNGX | Common Stock | D | 0,2050 | 243.902 | 50 | 243.902 | ||||
| 2010-06-21 | 2010-06-18 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 0,28 | 1 | 1 | |||||
| 2010-06-21 | 2010-06-18 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 0,2050 | 8.608.580 | 1.765 | 54.227.816 | ||||
| 2009-09-28 | 2009-09-24 | 4 | Essetifin SPA Indirect | DORB | Common Stock Warrant (right to buy) | I | 0,28 | 1 | 1 | |||||
| 2009-09-28 | 2009-09-24 | 4 | Essetifin SPA Indirect | DORB | Common Stock | I | 0,2530 | 3.952.569 | 1.000 | 45.619.236 | ||||
| 2009-02-13 | 2009-02-11 | 4 | Essetifin SPA Indirect | DORB | Common Stock | I | 0,1800 | 25.000.000 | 4.500 | 41.666.667 | ||||
| 2008-12-03 | 3 | Leadiant Biosciences, Inc. Indirect | DORB | Common Stock | I | 16.666.667 | ||||||||
| 2007-07-02 | 3 | Buhrman Cyrille F | DORB | Common Stock | D | 4.900.020 | ||||||||
| 2007-07-02 | 2007-06-28 | 4 | Buhrman Cyrille F | DORB | Stock Options (right to buy) | D | 0,33 | 150.000 | 150.000 | |||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0100 | -875.300 | -884 | 162.600 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0200 | -248.700 | -254 | 1.037.900 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0300 | -68.200 | -70 | 1.286.600 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0400 | -51.300 | -53 | 1.354.800 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0600 | -12.600 | -13 | 1.406.100 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0700 | -33.200 | -36 | 1.418.700 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0800 | -17.000 | -18 | 1.451.900 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0100 | -180.700 | -183 | 1.468.900 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0200 | -5.600 | -6 | 1.649.600 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0500 | -69.200 | -73 | 1.655.200 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0600 | -11.000 | -12 | 1.724.400 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0500 | -106.900 | -112 | 1.735.400 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0600 | -44.900 | -48 | 1.842.300 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0700 | -4.800 | -5 | 1.887.200 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0800 | -16.600 | -18 | 1.892.000 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0900 | -10.400 | -11 | 1.908.600 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,1000 | -81.000 | -89 | 1.919.000 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,1100 | -52.879 | -59 | 2.000.000 | ||||
| 2004-02-06 | 2004-02-04 | 4 | ELAN CORP PLC I | DOR | Series B Convertible Preferred Stock | I | 5,11 | 126.567 | 126.567 | |||||
| 2004-02-06 | 2002-12-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 500.000 | 2.052.879 | ||||||
| 2004-02-06 | 2002-10-21 | 4 | ELAN CORP PLC I | DOR | Series C Convertible Preferred Stock | I | 8,86 | -110.323 | 0 | |||||
| 2004-02-06 | 2002-10-21 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 8,8600 | 1.245.187 | 11.032 | 1.552.879 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
